Invention Grant
- Patent Title: Annexin A3 for cancer diagnosis
- Patent Title (中): 膜联蛋白A3用于癌症诊断
-
Application No.: US12770472Application Date: 2010-04-29
-
Publication No.: US08409812B2Publication Date: 2013-04-02
- Inventor: Michael Cahill , André Schrattenholz
- Applicant: Michael Cahill , André Schrattenholz
- Applicant Address: DE
- Assignee: ProteoSys AG
- Current Assignee: ProteoSys AG
- Current Assignee Address: DE
- Agency: DLA Piper LLP (US)
- Priority: EP05011042 20050521; EP05026092 20051130
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/567 ; G01N33/574 ; C07K14/00
Abstract:
A method treats urogenital and/or intestinal tract cancer and includes administering a therapeutically effective amount of at least one annexion protein, annexin of A3, to a mammal.
Public/Granted literature
- US20100267051A1 ANNEXIN FOR CANCER RISK ASSESSMENT Public/Granted day:2010-10-21
Information query
IPC分类:
